5-hydroxytryptamine1C receptor density and mRNA levels in choroid plexus epithelial cells after treatment with mianserin and (-)-1-(4- bromo-2,5-dimethoxyphenyl)-2-aminopropane

EL Barker and E Sanders-Bush

Department of Pharmacology, School of Medicine, Vanderbilt University, Nashville, Tennessee 37232-6600.

5-Hydroxytryptamine (5HT)1C and 5HT2 receptors display paradoxical down- regulation when exposed to receptor antagonists in vivo, a property that is unique to these two subtypes of serotonin (5HT) receptors. Because of the absence of cell culture model systems, the mechanisms involved in this paradoxical down-regulation have been difficult to explore. The present study focuses on the regulation of 5HT1C receptors in primary cultures of rat choroid plexus epithelial cells. Exposure of the epithelial cell cultures to 100 nM mianserin, a receptor antagonist, or (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane, an agonist, for 72 hr caused a loss of 5HT1C receptor binding sites, as determined by [3H]mesulergine binding to crude membrane preparations. No significant changes in Kd values were observed. Neither the agonist nor antagonist caused a significant change in binding sites after 24 hr. A solution hybridization assay was used to determine whether the down-regulation by mianserin or (-)-1-(4-bromo-2,5-dimethoxyphenyl)-2- aminopropane was accompanied by a decrease in the steady state level of 5HT1C receptor mRNA. These studies showed that neither treatment caused an alteration in the levels of 5HT1C receptor mRNA. Thus, it is possible to reproduce the in vivo regulatory effects of drugs on 5HT1C receptors in choroid plexus epithelial cells in culture, including the atypical down-regulation by receptor antagonists. Using this cell culture model system, indirect transynaptic effects and decreases in receptor mRNA levels have been ruled out as mechanisms accounting for the down-regulation.

Volume 44, Issue 4, pp. 725-730, 10/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				L. L. Parker, J. R. Backstrom, E. Sanders-Bush, and B.-H. Shieh Agonist-induced Phosphorylation of the Serotonin 5-HT2C Receptor Regulates Its Interaction with Multiple PDZ Protein 1 J. Biol. Chem., June 6, 2003; 278(24): 21576 - 21583. [Abstract] [Full Text] [PDF]

				L. McGrew, M. S. S. Chang, and E. Sanders-Bush Phospholipase D Activation by Endogenous 5-Hydroxytryptamine 2C Receptors Is Mediated by Galpha 13 and Pertussis Toxin-Insensitive Gbeta gamma Subunits Mol. Pharmacol., December 1, 2002; 62(6): 1339 - 1343. [Abstract] [Full Text] [PDF]

				V. J. Aloyo, K. D. Dave, T. Rahman, and J. A. Harvey Selective and Divergent Regulation of Cortical 5-HT2A Receptors in Rabbit J. Pharmacol. Exp. Ther., December 1, 2001; 299(3): 1066 - 1072. [Abstract] [Full Text] [PDF]

				M. Chang, L. Zhang, J. P. Tam, and E. Sanders-Bush Dissecting G Protein-coupled Receptor Signaling Pathways with Membrane-permeable Blocking Peptides. ENDOGENOUS 5-HT2C RECEPTORS IN CHOROID PLEXUS EPITHELIAL CELLS J. Biol. Chem., March 15, 2000; 275(10): 7021 - 7029. [Abstract] [Full Text] [PDF]

				K. A. Berg, B. D. Stout, J. D. Cropper, S. Maayani, and W. P. Clarke Novel Actions of Inverse Agonists on 5-HT2C Receptor Systems Mol. Pharmacol., May 1, 1999; 55(5): 863 - 872. [Abstract] [Full Text]

				K. A. BERG, S. MAAYANI, and W. P. CLARKE Interactions between Effectors Linked to Serotonin Receptors Ann. N.Y. Acad. Sci., December 15, 1998; 861(1): 111 - 120. [Abstract] [Full Text] [PDF]

				M. Rinaldi-Carmona, A. Le Duigou, D. Oustric, F. Barth, M. Bouaboula, P. Carayon, P. Casellas, and G. Le Fur Modulation of CB1 Cannabinoid Receptor Functions after a Long-Term Exposure to Agonist or Inverse Agonist in the Chinese Hamster Ovary Cell Expression System J. Pharmacol. Exp. Ther., December 1, 1998; 287(3): 1038 - 1047. [Abstract] [Full Text]

				D. S. Cowen, P. B. Molinoff, and D. R. Manning 5-Hydroxytryptamine1A Receptor-Mediated Increases in Receptor Expression and Activation of Nuclear Factor-kappa B in Transfected Chinese Hamster Ovary Cells Mol. Pharmacol., August 1, 1997; 52(2): 221 - 226. [Abstract] [Full Text]